+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-08-22Number of Pages: 165

Computer Aided Detection Market (Imaging Modality -Imaging Modality, Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT; Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Bone Cancer) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Computer Aided Detection Market: Snapshot

The global computer aided detection (CAD) market is in its early stages of growth and is increasingly reliant on the market dynamics of corresponding imaging modalities for market penetration. The growing usage of CAD software solutions for a number of diagnostic applications such as cardiovascular, oncology, musculoskeletal, and neurological has made the market highly specific, dynamic, and competitive with significant growth potential. The revenue generated by the global CAD market was pegged at US$437 mn in 2015 and is anticipated to cross US$1 bn by 2024. The market is expected to expand at a strong CAGR of 9.8% from 2016 to 2024.

Computer Aided Detection Most Widely Used in Breast Cancer Screening

Computer aided detection technology finds application mainly in oncology and cardiovascular and neurological indications. Breast cancer was the leading application segment of the market in 2015 and is projected to sustain its position during the forecast period. Its dominance can be attributed to the increasing number of breast cancer detection applications and a lower risk of observational errors by using CAD solutions in combination with mammography. Favorable reimbursement scenario for breast cancer CAD solutions in developed nations and its well-established identity as a supplement tool in the diagnosis of breast cancer also contribute to the growth of the segment. The prostate cancer application segment is projected to expand at the fastest growth rate from 2016 to 2024. This can be attributed to the increasing number of regulatory approvals for various prostate cancer detection CAD solutions and the rising incidence of the disease.

computer-aided-detection-market

Growing Incidence and Prevalence of Breast Cancer in U.S. Driving North America Market

Geographically, the computer aided detection market has been segmented into five major regions: North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. North America held the leading share in the global computer aided detection market in terms of revenue in 2015, followed by Europe. The dominance of these two regions is owing to the rising incidence and prevalence of breast cancer, the growing awareness level about early screening of breast cancer, an increase in the geriatric population, and rapid advancement in various healthcare technologies. The U.S. forms the most significant market for computer aided detection in North America as well as globally as it is an important innovation hub and leading companies in the segment have been conducting thorough research and development. Moreover, the World Cancer Research Fund (WCRF) statistics show that North America reported the highest number of new breast cancer cases in 2012, with around 226,125 in the U.S. alone. This also acts as a growth driver for the computer aided detection market in the region.

Asia Pacific is also a prominent market for computer aided detection. The region accounts for over 60% of the world’s population, which translates to a significant patient pool and large number of imaging procedures. According to the Asian Pacific Journal of Cancer Prevention (2010), there were over 3 million new cancer cases and over 2 million cancer deaths in Asia. Projections suggest the number of new cancer cases in Asia will increase to 7.1 million by 2020 if existing prevention and management strategies remain unchanged. However, most of the countries in the region are positioning themselves as medical tourism destinations for developed nations. This will encourage healthcare providers to adopt advanced computer aided detection in imaging technologies.

Key players in the computer aided detection market include Agfa-Gevaert N.V., Fujifilm Medical Systems USA, Inc., GE Healthcare, Hitachi Medical Corporation, Hologic, Inc., Samsung Medison Co. Ltd, and Philips Healthcare.

1. Preface
    1.1. Report Scope and Market Segmentation Market Segmentation
    1.2. Research Highlights

2. Assumptions and Research Methodology
    2.1. Assumptions and Acronyms Used
    2.2. Research Methodology

3. Executive Summary
    3.1. Global Computer Aided Detection: Market Snapshot
    3.2. Global Computer Aided Detection Market Revenue Projection

4. Market Overview
    4.1. Introduction
    4.2. Market Dynamics
           4.2.1. Drivers and Restraints Snapshot Analysis
           4.2.2. Drivers
                    4.2.2.1. Growing medical imaging market and increasing geriatric population
                    4.2.2.2. Investment inflows and mergers & acquisitions
                    4.2.2.3. Rise in demand for insurance boosts pre-screening requirements
                    4.2.2.4. Increase in incidence of various types of cancer
                    4.2.2.5. Increase in awareness about diagnosis
                    4.2.2.6. Adaptability in CAD technology promotes supplementary uses
           4.2.3. Restraints
                    4.2.3.1. Premium pricing of software solutions
                    4.2.3.2. Lack of skilled and experienced technicians and programmers
                    4.2.3.3. Opposition by conservative medical practitioners
           4.2.4. Opportunity Analysis
                      4.2.4.1. Evolution of artificial intelligence (AI) to assist in continuous development of CAD
                      4.2.4.2. BRICS is expected to become a vital market for overall computer aided detection systems
    4.3. Porter’s Five Forces Analysis
    4.4. Regulatory Scenario: Computer Aided Detection
    4.5. Computer Aided Detection Market Outlook

5. Computer Aided Detection Market - By Application
    5.1. Introduction
    5.2. Global Computer Aided Detection Market Value Share Analysis, by Application
    5.3. Breast Cancer
    5.4. Lung Cancer
    5.5. Colorectal Cancer
    5.6. Prostate Cancer
    5.7. Liver Cancer
    5.8. Bone Cancer
    5.9. Other Cancers
    5.10. Cardiovascular and Neurological Indications
    5.11. Computer Aided Detection Market Attractiveness Analysis, by Application

6. Computer Aided Detection Market Analysis, by Imaging Modality
    6.1. Introduction
    6.2. Global Computer Aided Detection Market Value Share Analysis, by Imaging Modality
    6.3. Mammography
    6.4. MRI
    6.5. Ultrasound Imaging
    6.6. Tomosynthesis
    6.7. CT
    6.8. Other Imaging Modalities
    6.9. Computer Aided Detection Market Attractiveness Analysis, by Imaging Modality

7. Global Computer Aided Detection Market Analysis, by Region
    7.1. Global Market Scenario
    7.2. Global Computer Aided Detection Market Value Share Analysis, by Region
    7.3. Global Computer Aided Detection Market Attractiveness Analysis, by Region

8. North America Computer Aided Detection Market Analysis
    8.1. North America Computer Aided Detection Market Overview
    8.2. North America Market Value Share Analysis, by Application
    8.3. North America Market Forecast, by Application
    8.4. North America Market Value-Share Analysis, by Imaging Modality
    8.5. North America Market Value-Share Analysis, by Country
    8.6. North America Market Forecast, by Country
           8.6.1. U.S. Computer Aided Detection Market Analysis
           8.6.2. Canada Computer Aided Detection Market Analysis
    8.7. North America Market Attractiveness Analysis

9. Europe Computer Aided Detection Market Analysis
    9.1. Europe Computer Aided Detection Market Overview
    9.2. Europe Market Value Share Analysis, by Application
    9.3. Europe Market Forecast, by Application
    9.4. Europe Market Value-Share Analysis, by Imaging Modality
    9.5. Europe Market Value-Share Analysis, by Country
    9.6. Europe Market Forecast, by Country
           9.6.1. Germany Computer Aided Detection Market Analysis
           9.6.2. U.K. Computer Aided Detection Market Analysis
           9.6.3. Rest of Europe Computer Aided Detection Market Analysis
    9.7. Europe Market Attractiveness Analysis

10. Asia Pacific Computer Aided Detection Market Analysis
    10.1. Asia Pacific Computer Aided Detection Market Overview
    10.2. Asia Pacific Market Value Share Analysis, by Application
    10.3. Asia Pacific Market Forecast, by Application
    10.4. Asia Pacific Market Value-Share Analysis, by Imaging Modality
    10.5. Asia Pacific Market Value-Share Analysis, by Country
    10.6. Asia Pacific Market Forecast, by Country
           10.6.1. Japan Computer Aided Detection Market Analysis
           10.6.2. China Computer Aided Detection Market Analysis
           10.6.3. Rest of Asia Pacific Computer Aided Detection Market Analysis
    10.7. Asia Pacific Market Attractiveness Analysis

11. Latin America Computer Aided Detection, Market Analysis
    11.1. Latin America Computer Aided Detection Market Overview
    11.2. Latin America Market Value Share Analysis, by Application
    11.3. Latin America Market Forecast, by Application
    11.4. Latin America Market Value-Share Analysis, by Imaging Modality
    11.5. Latin America Market Value-Share Analysis, by Country
    11.6. Latin America Market Forecast, by Country
           11.6.1. Brazil Computer Aided Detection Market Analysis
           11.6.2. Rest of Latin America Computer Aided Detection Market Analysis
    11.7. Latin America Market Attractiveness Analysis

12. Middle East & Africa (MEA) Computer Aided Detection, Market Analysis
    12.1. Middle East & Africa (MEA)Computer Aided Detection Market Overview
    12.2. Middle East & Africa (MEA) Market Value Share Analysis, by Application
    12.3. Middle East & Africa (MEA) Market Forecast, by Application
    12.4. Middle East & Africa (MEA) Market Value-Share Analysis, by Imaging Modality
    12.5. Middle East & Africa (MEA) Market Value-Share Analysis, by Country
    12.6. Middle East & Africa (MEA) Market Forecast, by Country
           12.6.1. South Africa Computer Aided Detection Market Analysis
           12.6.2. Rest of Middle East & Africa (MEA) Computer Aided Detection Market Analysis
    12.7. Middle East & Africa (MEA) Market Attractiveness Analysis

13. Competition Landscape
    13.1. Computer Aided Detection Market Share Analysis by Company (2015)
    13.2. Company Profiles
           13.2.1. Agfa-Gevaert N.V.
                    13.2.1.1. Company Details
                    13.2.1.2. Business Overview
                    13.2.1.3. SWOT Analysis
                    13.2.1.4. Financials
                    13.2.1.5. Strategic Overview
                    13.2.1.6. Product Portfolio
           13.2.2. Fujifilm Holdings Corporation
                    13.2.2.1. Company Details
                    13.2.2.2. Business Overview
                    13.2.2.3. SWOT Analysis
                    13.2.2.4. Financials
                    13.2.2.5. Strategic Overview
                    13.2.2.6. Product Portfolio
           13.2.3. GE Healthcare
                    13.2.3.1. Company Details
                    13.2.3.2. Business Overview
                    13.2.3.3. SWOT Analysis
                    13.2.3.4. Financials
                    13.2.3.5. Strategic Overview
                    13.2.3.6. Product Portfolio
           13.2.4. Hitachi Medical Corporation
                    13.2.4.1. Company Details
                    13.2.4.2. Business Overview
                    13.2.4.3. SWOT Analysis
                    13.2.4.4. Financials
                    13.2.4.5. Strategic Overview
                    13.2.4.6. Product Portfolio
           13.2.5. Hologic, Inc. 
                    13.2.5.1. Company Details
                    13.2.5.2. Business Overview
                    13.2.5.3. SWOT Analysis
                    13.2.5.4. Financials
                    13.2.5.5. Strategic Overview
                    13.2.5.6. Product Portfolio
           13.2.6. iCAD, Inc.
                    13.2.6.1. Company Details
                    13.2.6.2. Business Overview
                    13.2.6.3. SWOT Analysis
                    13.2.6.4. Financials
                    13.2.6.5. Strategic Overview
                    13.2.6.6. Product Portfolio
           13.2.7. Invivo Corporation
                    13.2.7.1. Company Details
                    13.2.7.2. Business Overview
                    13.2.7.3. SWOT Analysis
                    13.2.7.4. Financials
                    13.2.7.5. Strategic Overview
                    13.2.7.6. Product Portfolio
           13.2.8. McKesson Corporation
                    13.2.8.1. Company Details
                    13.2.8.2. Business Overview
                    13.2.8.3. SWOT Analysis
                    13.2.8.4. Financials
                    13.2.8.5. Strategic Overview
                    13.2.8.6. Product Portfolio
           13.2.9. Merge Healthcare Incorporated (IBM)
                    13.2.9.1. Company Details
                    13.2.9.2. Business Overview
                    13.2.9.3. SWOT Analysis
                    13.2.9.4. Financials
                    13.2.9.5. Strategic Overview
                    13.2.9.6. Product Portfolio
           13.2.10. Philips Healthcare
                    13.2.10.1. Company Details
                    13.2.10.2. Business Overview
                    13.2.10.3. SWOT Analysis
                    13.2.10.4. Financials
                    13.2.10.5. Strategic Overview
                    13.2.10.6. Product Portfolio
           13.2.11. Samsung Medison Co. Ltd.
                    13.2.11.1. Company Details
                    13.2.11.2. Business Overview
                    13.2.11.3. SWOT Analysis
                    13.2.11.4. Financials
                    13.2.11.5. Strategic Overview
                    13.2.11.6. Product Portfolio
           13.2.12. Siemens Healthcare
                    13.2.12.1. Company Details
                    13.2.12.2. Business Overview
                    13.2.12.3. SWOT Analysis
                    13.2.12.4. Financials
                    13.2.12.5. Strategic Overview
                    13.2.12.6. Product Portfolio
           13.2.13. Toshiba Medical Systems Corporation
                    13.2.13.1. Company Details
                    13.2.13.2. Business Overview
                    13.2.13.3. SWOT Analysis
                    13.2.13.4. Financials
                    13.2.13.5. Strategic Overview
                    13.2.13.6. Product Portfolio

14 Key Takeaways

List of Figures

Figure 01 - Global Computer Aided Detection Market Size (US$ Mn) Forecast, 2015–2024
Figure 02 - Global Computer Aided Detection Market Value Share Analysis, by Application, 2016 and 2024
Figure 03 - Global Breast Cancer Market Revenue (US$ Mn), 2015–2024
Figure 04 - Global Lung Cancer Market Revenue (US$ Mn), 2015–2024
Figure 05 - Global Colorectal Cancer Market Revenue (US$ Mn), 2015–2024
Figure 06 - Global Prostate Cancer Market Revenue (US$ Mn), 2015–2024
Figure 07 - Global Liver Cancer Market Revenue (US$ Mn), 2015–2024
Figure 08 - Global Bone Cancer Market Revenue (US$ Mn), 2015–2024
Figure 09 - Global Other Cancers Market Revenue (US$ Mn), 2015–2024
Figure 10 - Global Cardiovascular and Neurological Indications Cancer Market Revenue (US$ Mn), 2015–2024
Figure 11: Computer Aided Detection Market Attractiveness Analysis, by Application
Figure 12: Global Computer Aided Detection Market Value Share Analysis, by Imaging Modality, 2016 and 2024
Figure 13- Global Mammography Market Revenue (US$ Mn), 2015– 2024
Figure 14 - Global MRI Market Revenue (US$ Mn), 2015–2024
Figure 15 - Global Ultrasound Imaging Market Revenue (US$ Mn), 2015–2024
Figure 16 - Global Tomosynthesis Market Revenue (US$ Mn), 2015–2024
Figure 17 - Global CT Market Revenue, (US$ Mn), 2015–2024
Figure 18- Global Other Imaging Modalities Market Revenue (US$ Mn), 2015–2024
Figure 19: Computer Aided Detection Market Attractiveness Analysis, by Imaging Modality
Figure 20: Global Computer Aided Detection Market Value Share Analysis, by Region, 2016 and 2024
Figure 21: Computer Aided Detection Market Attractiveness Analysis, by Region
Figure 23: North America Market Value Share Analysis, by Application, 2016 and 2024
Figure 24: North America Market Value-Share Analysis, by Imaging Modality, 2016 and 2024
Figure 25: North America Market Value Share Analysis, by Country, 2016 and 2024
Figure 26: Europe Computer Aided Detection Market Size (US$ Mn) Forecast, 2015–2024
Figure 27: Europe Market Attractiveness Analysis, by Country
Figure 28: Europe Market Value Share Analysis, by Application, 2016 and 2024
Figure 29: Europe Market Value Share Analysis, by Imaging Modality, 2016 and 2024
Figure 30: Europe Market Value Share Analysis, by Country, 2016 and 2024
Figure 31: Asia Pacific Computer Aided Detection Market Size (US$ Mn) Forecast, 2015–2024
Figure 32: Asia Pacific Market Attractiveness Analysis, by Country/Region
Figure 33: Asia Pacific Market Value Share Analysis, by Application, 2016 and 2024
Figure 34: Asia Pacific Market Value Share Analysis, by Imaging Modality, 2016 and 2024
Figure 35: Asia Pacific Market Value Share Analysis, by Country, 2016 and 2024
Figure 36: Latin America Computer Aided Detection, Market Size (US$ Mn) Forecast, 2015–2024
Figure 37: Latin America Market Attractiveness Analysis, By Country
Figure 38: Latin America Market Value Share Analysis, by Application, 2016 and 2024
Figure 39: Latin America Market Value Share Analysis, by Imaging Modality, 2016 and 2024
Figure 40: Latin America Market Value Share Analysis, by Country/Region, 2016 and 2024
Figure 41: MEA Computer Aided Detection Market Size (US$ Mn) Forecast, 2015–2024
Figure 42: MEA Market Attractiveness Analysis, by Country
Figure 43: MEA Market Value Share Analysis, by Application, 2016 and 2024
Figure 44: Middle East & Africa Market Value Share Analysis, by Imaging Modality, 2016 and 2024
Figure 45: Middle East & Africa Market Value Share Analysis, by Country, 2016 and 2024
Figure 46: Global Computer Aided Detection Market Share Analysis by Company (2015)

List of Tables

TABLE 1 Global Computer Aided Detection Market Size (US$ Mn), by Application, 2015–2024
TABLE 2 Global Computer Aided Detection Market Size (US$ Mn), by Imaging Modality, 2015–2024
TABLE 3 Global Computer Aided Detection Market Size (US$ Mn) Forecast, by Region, 2015–2024
TABLE 4 North America Computer Aided Detection Market Size (US$ Mn) Forecast, by Application, 2015–2024
TABLE 5 North America Computer Aided Detection Market Size (US$ Mn) Forecast, by Imaging Modality, 2015–2024
TABLE 6 Global Computer Aided Detection Market Size (US$ Mn) Forecast, by Country, 2015–2024
TABLE 7 Europe Computer Aided Detection Market Size (US$ Mn) Forecast, by Application, 2015–2024
TABLE 8 Europe Computer Aided Detection Market Size (US$ Mn) Forecast, by Imaging Modality, 2015–2024
TABLE 9 Europe Computer Aided Detection Market Size (US$ Mn) Forecast, by Country, 2015–2024
TABLE 10 Asia Pacific Computer Aided Detection Market Size (US$ Mn) Forecast, by Application, 2015–2024
TABLE 11 Asia Pacific Computer Aided Detection Market Size (US$ Mn) Forecast, by Imaging Modality, 2015–2024
TABLE 12 Asia Pacific Computer Aided Detection Market Size (US$ Mn) Forecast, by Country, 2015–2024
TABLE 13 Latin America Computer Aided Detection Market Size (US$ Mn) Forecast, by Application, 2015–2024
TABLE 14 Latin America Computer Aided Detection Market Size (US$ Mn) Forecast, by Imaging Modality, 2015–2024
TABLE 15 Latin America Computer Aided Detection Market Size (US$ Mn) Forecast, by Country, 2015–2024
TABLE 16 Middle East & Africa Computer Aided Detection Market Size (US$ Mn) Forecast, by Application, 2015–2024
TABLE 17 MEA Computer Aided Detection Market Size (US$ Mn) Forecast, by Imaging Modality, 2015–2024
TABLE 18 MEA Computer Aided Detection Market Size (US$ Mn) Forecast, by Country/Region, 2015–2024

Computer aided detection (CAD) is a clinically established tool that helps in the diagnosis or detection of cancers, and cardiovascular and neurological diseases. These systems assist physicians to decrease false negative rate, detect cancer at early stages, reduce mortality rates caused due to cancer and other diseases, and improve inter and intra reader variability. Additionally, CAD systems are extensively used to help physicians in numerous tasks that include providing a second opinion to the diagnostic and detection outcomes and automatically recognizing all non-calcified lesions doubted of malignancy at images. A CAD system helps in diagnosis, detection, and risk assessment. The purpose of using a computer and CAD tools is to help in medical image diagnosis. Technologically advanced CAD systems provide a moderately trained physician the same diagnostic skills as an experienced radiologist. CAD has also been used to increase the sensitivity of diagnostic imaging in medical investigation and differential diagnostics.

This research study analyzes the market for computer aided detection in terms of revenue (US$ Mn). The market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. The report also includes key market dynamics, such as drivers, restraints, and opportunities, affecting the demand for computer aided detection products globally and country wise. Comparative analysis has also been included in the executive summary for each region of 2016 and 2024.

The report provides in-depth analysis of the computer aided detection market. The stakeholders of this report include companies engaged in the manufacture of CAD products used along with medical imaging equipment in screening of cancers and other diseases. The executive summary section is included in this report to provide a snapshot of the market. It summarizes the market size, trends, and competition in different regions.

The market overview section of this report analyzes market dynamics such as drivers, restraints, and opportunities that influence the computer aided detection market in the current and future scenario. Market share analysis is provided to signify percentage share of the major players operating in the computer aided detection market. These factors will help the market players to chalk out business strategies and plans to strengthen their positions in the global market.

Based on application, the computer aided detection market has been segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, liver cancer, other cancers, and other disease. In terms of imaging modality, the market has been segmented into mammography, magnetic resonance imaging, ultrasound imaging, tomosynthesis, CT, and others.

In terms of region, the computer aided detection market has been segmented into four major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries such as the U.S., Canada, Germany, the U.K., Japan China, Russia, Brazil, Mexico, and South Africa have been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the market in various regions has been provided in this section.

The report provides market estimation of the computer aided detection market in terms of revenue (US$ Mn) for all the segments and sub segments, with CAGR % for the period from 2016 to 2024, considering 2015 as the base year. Furthermore, the report incorporates market attractiveness analysis by product category that depicts the most attractive product segment in the global market during the forecast period from 2016 to 2024.

This report also includes a recommendations section that will assist new companies to establish their presence and existing market players to expand their market shares in the computer aided detection market. The report concludes with the company profile section, which includes company overview, financial overview, product portfolio, business strategies, and recent developments of market players. Key players profiled in the report include Agfa-Gevaert N.V., Fujifilm Medical Systems USA, Inc., GE Healthcare, Hitachi Medical Corporation, Hologic, Inc., Samsung Medison Co. Ltd, and Philips Healthcare.

The global computer aided detection market has been segmented as follows:

 

Computer Aided Detection Market, by Application

  • Oncology
    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Liver Cancer
    • Bone Cancer
    • Other Cancer
  • Cardiovascular and Neurological Indications

Computer Aided Detection Market, by Imaging Modality

  • Mammography
  • Ultrasound Imaging
  • Magnetic Resonance Imaging
  • Tomosynthesis
  • Computed Tomography
  • Others

Computer Aided Detection Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • Germany
    • U.K.
    • Rest Of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
  • Rest of Middle East & Africa


 
 
Back To Top